Inhaled nitric oxide for the prevention of bronchopulmonary dysplasia

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 10, 2007, Pages 1505-1513

  Truog, William E ^a,b,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

^c UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Inhaled nitric oxide; Randomized clinical trials

Indexed keywords

ACETYLCYSTEINE; ALPHA 1 ANTITRYPSIN; ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; CORTICOSTEROID; DEXAMETHASONE; LUNG SURFACTANT; NITRIC OXIDE; PLACEBO; RETINOL; SILDENAFIL; THYROXINE;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASSISTED VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DOSE CALCULATION; HORMONE SUBSTITUTION; HUMAN; HYPOXIA; INCIDENCE; LOW BIRTH WEIGHT; LOW DRUG DOSE; LUNG DYSPLASIA; NEWBORN MORTALITY; NONHUMAN; OXYGEN THERAPY; PATIENT SELECTION; PREMATURITY; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; REVIEW; RISK REDUCTION; SURVIVAL RATE;

ADMINISTRATION, INHALATION; BRONCHOPULMONARY DYSPLASIA; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NITRIC OXIDE; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34447648324     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.10.1505     Document Type: Review

References (46)

1. JOBE AH, BANCALARI E: Bronchopulmonary dysplasia. NICHD/NHLBI/ORD workshop summary. Am. J. Respir. Crit. Care Med. (2001) 163:1723-1729.
2. JOBE AJ: The new BPD: an arrest of lung development. Pediatr. Res. (1999) 46:641-643.
3. TRUOG WE: Chronic lung disease and randomized interventional trials: status in 2005. NeoReviews (2005) 6:e278-e288.
4. THE OFFICIAL STATEMENT OF THE AMERICAN THORACIC SOCIETY Statement on the care of the child with chronic lung disease of infancy and childhood. Am. J. Respir. Crit. Care Med. (2003) 168:356-396.
5. KILBRIDE HW, GELATT MC, SABATH RJ: Pulmonary function and exercise capacity for ELBW survivors in preadolescence: effect of neonatal chronic lung disease. J. Pediatr. (2003) 143:488-493.
6. DE PAEPE ME, MAO Q, POWELL J et al.: Growth of pulmonary microvasculature in ventilated preterm infants. Am. J. Respir. Cirit. Care Med. (2006) 173:204-211.
7. BHANDARI V, BIZZARRO MJ, SHETTY A et al.: Familial and genetic susceptibility to major neonatal morbidities in preterm twins. Pediatrics (2006) 117:1901-1906.
8. TYSON JE, WRIGHT LL, OH W et al.: Vitamin A supplementation for extremely low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N. Engl. J. Med. (1999) 340:1962-1968.
9. SMITH LM, LEAKE RD, BERMAN N, VILLANUEVA S, BRASEL J: Postnatal thyroxine supplementation in infants less than 32 weeks' gestation: effects on pulmonary morbidity. J. Perinatol. (2000) 20:427-431.
10. SURESH GK, DAVIS JM, SOLL RF: Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterrin infants. Cochrane Database Sys. Rev. (2001) 1:CD001968.
11. DAVIS JM, PARAD RB, MICHELE T, ALLRED E, PRICE A, ROSENFELD W; FOR THE NORTH AMERICAN RECOMBINANT HUMAN CUZNSOD STUDY GROUP: Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismucase. Pediatrics (2003) 111:469-476.
12. AHOLA T, LAPATTO R, RAIVIO KO et al.: N-acetylcysteine does not prevent bronchopulmonary dysplasia. in immature infants: a randomized controlled trial. J. Pediatr. (2003) 143:713-719.
13. STISKAL JA, DUNN MS, SHENNAN AT et al.: α1-Proteinase inhibitor therapy for the prevention of chronic lung disease of prematurity: a randomized, controlled trial. Pediatrics (1998) 101:89-94.
14. AMERICAN ACADEMY OF PEDIATRICS: COMMITTEE ON FETUS AND NEWBORN; CANADIAN PEDIATRIC SOCIETY. FETUS AND NEWBORN COMMITTEE: Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics (2002) 109:330-338.
15. HALLIDAY HL, EHRENKRANZ RA, DOYLE LW. Early postnatal (< 96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review); In: The Cochrane Library, Issue 2, Chichester, Wiley (2004).
16. THE NEONATAL INHALED NITRIC OXIDE STUDY GROUP: Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. N. Engl. J. Med. (1997) 336:597-604.
17. DAVIDSON D, BAREFIELD ES, KATTWINKEL J et al.: Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. Pediatrics (1998) 101:325-334.
18. CLARK RH, KEUSER TJ, WALKER MW et al.: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N. Engl. J. Med. (2000) 342:469-474.
19. GASTON B, SINGEL D, DOCTOR A, STAMLER JS: S-nitrosothiol signaling in respiratory biology. Am. J. Respir. Crit. Care Med. (2006) 173:1186-1193.
20. RICCIARDOLO F, STERK P, GASTON B, FOLKERTS G: Nitric oxide in health and disease of the respiratory system. Physiol Rev. (2004) 84:731-765.
21. BLAND RD, ALBERTINE KH, CARLTON DP, MACRITCHIE AJ: Inhaled nitric oxide effects on lung structure and hinction in chronically ventilated preterm lambs. J. Resp. Crit. Care Med. (2005) 172:899-906.
22. SRISUPARP P, HEITSCHMIDT M, SCHREIBER MD: Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome. J. Med. Assoc. Thai. (2002) 85:S469-S478.
23. KINSELLA JP, WALSH WF, BOSE CL et al.: Inhaled nitric oxide in premature neonates with severe hypoxaemic respiratory failure: a randomized controlled trial. Lancet (1999) 354:1061-1065.
24. SUBHEDAR NV, RYAN SW, SHAW NJ: Open randomized controlled trial of inhaled nitric oxide and early dexamethasone in high-risk preterm infants. Arch. Dis. Child Fetal Neonatal Ed. (1997) 77:F185-F190.
25. THE FRANCO-BELGIUM COLLABORATIVE No TRIAL GROUP: Early compared with delayed inhaled nitric oxide in moderately hypoxaemic neonates with respiratory failure: a randomized controlled trial. Lancet (1999) 354:1066-1071.
26. SKIMMING JW, BENDER KA, HUTCHISON AA, DRUMMOND WH: Nitric oxide inhalation in infants with respiratory distress syndrome. J. Pediatr. (1997) 130:225-230.
27. VAN MEURS KP, RHINE WD, ASSELIN JM, DURAND DJ: Response of premature infants with severe respiratory failure to inhaled nitric oxide. Preemie NO Collaborative Group. Pediatr. Pulmonol. (1997) 24:319-323.
28. CLARK PL, EKEKEZIE II, KAFTAN HA, CASTOR CA, TRUOG WE: Safety and cfficacy of nitric oxide in chronic lung disease. Arch. Dis. Child Fetal Neonatal Ed. (2002) 86:F41-F45.
29. BANKS BA, SERI I, ISCHIROPOULOS H, MERRILL J, RYCHIK J, BALLARD RA: Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia. Pediatrics (1999) 103:610-618.
30. DIMITRIOU G, GREENOUGH A, KAWAD IA V, DEVANE SP, RENNIE JM: Outcome predictors in nitric oxide treated preterm infants. Eur. J. Pediatr. (1999) 158:589-591.
31. AHLUWALIA J, TOOLEY J, CHEEMA I et al.: A dose response study of inhaled nitric oxide in hypoxic respiratory failure in preterm infants. Early Hum. Dev. (2006) 82:477-483.
32. HASCOET JM, FRESSON J, CLARIS O et al.: The safety and efficacy of nitric oxide therapy in premature infants. J. Pediatr. (2005) 146:318-323.
33. SCHREIBER MD, GIN-MESTAN K, MARKS JD, HUO D, LEE G, SRISUPARP P: Inhaled nitric oxide in premature infants with the respiratory distress syndrome. N. Engl. J. Med. (2003) 349:2099-2107.
34. FIELD D, ELBOURNE D, TRUESDALE A et al.: Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomized controlled trial (ISRCTN 17821339). Pediatrics (2005) 115:926-936.
35. VAN MEURS KR WRIGHT LL, EHRENKRANZ RA et al.: Inhaled nitric oxide for premature infants with severe respiratory &ilure. N. Engl. J. Med. (2005) 343:13-22.
36. KINSELLA JP, CUTTER GR, WALSH WF et al.: Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N. Engl. J. Med. (2006) 355:354-364.
37. BALLARD RA, TRUOG WE, CNAAN A et al.: Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N. Engl. J. Med. (2006) 355:343-353.
38. DANI C, BERTINI G, PEZZATI M, FILIPPI L, CECCHI A, RUBALTELLI FF: Inhaled nitric oxide in very preterm. infants with severe respiratory distress syndrome. Acta Paediatr. (2006) 95:1116-1123.
39. VAN MEURS KP: Inhaled nitric oxide therapy in the preterm infant who has respiratory distress syndrome. NeoReviews (2005) 6:e268-e277.
40. TRUOG WE, BALLARD PL, NORBERG M et al.: Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics (2007) 119(4):670-678.
41. MESTAN KKL, MARKS JD, HECOX K, HUO D, SCHREIBER MD: Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide. N. Engl. J. Med. (2005) 353:23-32.
42. MARTIN RJ, WALSH MC: Inhaled nitric oxide for preterm infants - who benefits? N. Engl. J. Med. (2005) 353:82-84.
43. STARK AR: Inhaled NO for preterm. inFants - getting to yes? N. Engl. J. Med. (2006) 355:404-406.
44. OLSEN SL, CLARK PL, THIBEAULT DW, NORBERG M, TRUOG WE: Exhaled nitric oxide and tracheal endothelin-1 in preterm, infants with and without RDS. Pediatr Pulm. (2003) 36:421-426.
45. SHEFFIELD M, MABRY S, THIBEAULT DW, TRUOG WE: Pulmonary nitric oxide synthases and nitrotyrosine: findings during lung development and in chronic lung disease of prematurity. Pediatrics (2006) 118:1056-1064.
46. SCHMIDT B, ROBERTS RS, DAVIS P et al.: Caffeine therapy for apnea of prematurity. N. Engl J. Med. (2006) 354:2112-2121.